ODDB.org: Open Drug Database

Eligard 45 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension -

Swissmedic Key	58431001	Registration Holder	Recordati AG
Name	Eligard 45 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension	Date of registration	31.01.2008
		Introduction of Sequence	31.01.2008
ATC-Classification	Leuprorelin (L02AE02)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.20.	Show package size
Index Therapeuticus (Swissmedic)	07.16.20.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	622.70	Limitation	No

Deductible	10 %	Consumer price	693.65
Feedback	FB	Daily cost
GTIN	7680584310011	Medication Code	Synthetika
Pharmacode	7772530	Disponibility

Composition

Praeparatio cryodesiccata: leuprorelini acetas 45 mg pro vitro. Solvens: poly(lactidum-co-glycolidum) 85/15, N-methylpyrrolidonum, pro vitro.

Packungsbestandteile

Label

Solvens

Galenic Form

Injection preparation

Excipiens

BAG: Active Agent	Dose
Leuproreline Acetate	45 mg

Inactive agents
N-Methylpyrrolidonum
Poly(Lactidum-Co-Glycolidum)

Label

Praeparatio cryodesiccata:

Galenic Form

Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension

Excipiens

Active Agent	Dose
Leuproreline Acetate	45 mg

BAG: Active Agent	Dose
Leuproreline Acetate	45 mg

Label

Solvens

Galenic Form

Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension

Excipiens

BAG: Active Agent	Dose
Leuproreline Acetate	45 mg

Inactive agents	Dose
N-Methylpyrrolidonum
Poly(Lactidum-Co-Glycolidum)	85

Source

Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH